Label: EMERGENCY CONTRACEPTIVE- levonorgestrel tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated June 27, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each tablet)

    Levonorgestrel 1.5 mg

  • Purpose

    Emergency contraceptive

  • Use

    for women to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control)

  • Warnings

    Allergy alert: Do not use if you have ever had an allergic reaction to levonorgestrel

    Sexually transmitted diseases (STDs) alert: This product does not protect against HIV/AIDS or other STDs

    Do not use

    • if you are already pregnant (because it will not work)
    • for regular birth control 

    Ask a doctor or pharmacist before use if you are

    taking efavirenz (HIV medication) or rifampin (tuberculosis treatment) or medication for seizures (epilepsy). These medications may reduce the effectiveness of levonorgestrel.

    When using this product you may have

    • menstrual changes
    • tiredness
    • breast pain
    • nausea
    • headache
    • vomiting
    • lower stomach (abdominal) pain
    • dizziness
  • Keep out of reach of children

    In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222)  right away.

  • Directions

    • take as soon as possible within 72 hours (3 days) after unprotected sex. The sooner you take it the better it will work.
    • if you vomit within 2 hours after taking the medication, call a healthcare professional to find out if you should repeat the dose.
  • Other information

    • read the instructions, warnings and enclosed product leaflet before use
      • this product works mainly by preventing ovulation (egg release). It may also prevent fertilization of a release egg (joining of sperm and egg) or attachment of a fertilized egg to the uterus (implantation)
    • do not use if package is open or blister seal is broken or missing
    • store at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted to 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature].
  • Inactive ingredients

    croscarmellose sodium, lactrose monohydrate, magnesium stearate, microcrystalline cellulose, poloxamer 188

  • Questions or comments?

    Call 1-877-753-3935 Monday-Friday 9AM-5PM EST

  • Principal display panel

    Compare to the active ingredient in Plan B One-Step®†

    emergency contraceptive

    levonorgestrel

    Tablet 1.5 mg

    one tablet. one step.

    • the sooner you take it, the more effective it will be
    • take as soon as possible within 72 hours (3 days) after unprotected sex
    • will not harm an existing pregnancy

    reduces chance of pregnancy after unprotected sex not for regular birth control

    tablet 1.5 mg

    †This product is not manufactured or distributed by Foundation Consumer Healthcare LLC, distributor of Plan B One Step®.

    Distributed by:

    PL Developments

    200 Hicks Street

    Westbury, NY 11590

  • Package Label

    Levonorgestrel 1.5 mg

    READYinCASE Emergency Contraceptive

  • INGREDIENTS AND APPEARANCE
    EMERGENCY CONTRACEPTIVE 
    levonorgestrel tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:59726-138(NDC:70700-164)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LEVONORGESTREL (UNII: 5W7SIA7YZW) (LEVONORGESTREL - UNII:5W7SIA7YZW) LEVONORGESTREL1.5 mg
    Inactive Ingredients
    Ingredient NameStrength
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    POLOXAMER 188 (UNII: LQA7B6G8JG)  
    Product Characteristics
    ColorwhiteScoreno score
    ShapeROUNDSize6mm
    FlavorImprint Code C;1
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:59726-138-011 in 1 CARTON08/01/2023
    11 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20532908/01/2023
    Labeler - P & L Development, LLC (800014821)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!